Gene Query: H2AFY2

Dataset Description Geneva Score
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 113.04
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 73.31
RNA-Seq from early time points in the kidney differentiation protocol 46.13
RNA sequencing analysis of human embryonic stem cells and axial progenitors 40.74
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 38.96
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 36.23
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 35.83
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 35.43
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 33.4
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 33.23
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 32.12
DIGIT regulates endoderm differentiation of human embryonic stem cells 30.51
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 29.93
DJ-1 is dispensable for human stem cell homeostasis 28.07
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 27.29
A transcriptome-wide divergence in protein translation scales with LIN28B expression 26.48
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 26.34
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 25.83
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 25.54
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 25.54
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 25.32
Global gene expression profile of dasatinib-resistant RCH-ACV cells 25.29
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 24.95
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 24.95
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 24.82
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 24.39
Lineage specific differentiation is influenced by state of human pluripotency 24.39
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 24.15
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 24.15
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 24.14
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 23.82
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 23.15
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 22.7
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 22.7
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 22.42
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 22.16
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 21.79
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 21.43
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 21.38
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 20.97
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 20.97
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 20.78
Control of prostate tumour growth by the long non-coding RNA GHSROS 20.32
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 19.44
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 19.14
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 18.41
WRN knockout effects upon gene expression in SW48 and OVK18 18.14
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 17.98
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 17.86
Gene expressions of H9s in different culture systems 17.41
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 17.33
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 17.18
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 17.18
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 17.03
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 16.94
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 16.84
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 16.49
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 16.16
EP400 is required for Max and MCPyV mediated gene activation 15.74
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 15.68
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 15.42
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 15.35
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 15.32
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 15.19
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 15.19
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 15.15
LNCaP treated with iBET 15.13
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 15.05
MYCL and EP400 are required for Max and MCPyV mediated gene activation 14.87
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 14.7
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 14.62
EWS-Fli and LNC regulated genes in comparison to GFP samples 14.3
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 14.26
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 14.13
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 14.02
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 14.02
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 13.92
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 13.84
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 13.79
mRNA-Seq profiling of human developing kidney 13.74
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 13.7
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 13.63
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 13.43
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 13.42
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 13.33
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 13.29
RNA-seq analysis of RALD iPSCs after in vitro differentiation 13.22
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 13.09
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 13.05
Next Generation Sequencing of human SMA and healthy control Motor Neurons 13.03
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 12.72
SOX11 knockdown in B-ALL cell lines 12.69
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 12.13
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 12.12
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 11.93
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 11.89
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 11.74
Genome-wide chromatin analysis of Ewing sarcoma 11.67
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 11.67
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 11.65
Total RNA sequencing of APC mutant and wt colonic organoids 11.36
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 11.07
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 11.0
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 10.91
Gene induction by the USP6 oncogene in response to interferon 10.79
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 10.77
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 10.76
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 10.7
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 10.7
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 10.7
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 10.69
RNA-Sequencing of HepG2 cells treated with TGFBeta 10.52
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 10.35
Transcriptome analysis of Zika infected neural stem cells 10.33
Zika infected neural stem cells 10.33
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 10.29
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 10.25
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 10.17
Tracking of dCas9-methyltransferase footprints 10.16
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 10.15
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 10.07
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 10.03
R430: A potent inbibitor of DNA and RNA viruses 9.92
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 9.84
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 9.83
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 9.8
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 9.8
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 9.78
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 9.67
Mechanistic Model-Guided Study of Embryonic Morphogenesis 9.53
Single-cell analysis of adult human ovary using 10X genomics 9.53
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 9.48
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 9.47
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 9.35
hESC neural differentiation 9.32
RNA-seq analysis of gene expression patterns during hESC neural differentiation 9.32
Differetially expressed genes after hTR overexpression in U2OS cells 9.31
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 9.27
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 9.23
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 9.14
MEIS1 regulates hematopoiesis in hPSCs 9.08
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 9.08
scRNASeq analysis of cycling cardiomyocytes 9.07
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 9.06
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 8.9
MARS Seq data from human cortical organoids 8.85
RNAseq analysis of ESRP regulated splicing events in prostate cancer 8.83
SNHG5 siRNA knock down in HCT116 cells 8.69
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 8.68
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 8.68
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 8.67
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 8.61
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 8.58
IRF1 regulates IFN dependent and independent gene expression 8.57
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 8.56
Global analysis of alternative splicing regulated by RBM10 8.51
Biological effect of chronic mistranslation in mammalian cells 8.41
Functional Haploid Human Oocytes Generated from Polar Body Genomes 8.34
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 8.34
High level DNA repair gene expression in human ES cells 8.33
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 8.26
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 8.23
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 8.23
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 8.2
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 8.01
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 8.01
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 8.01
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 8.0
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 7.98
Tyrosine Kinase Inhibitor Cardiotoxicity 7.91
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 7.91
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 7.9
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 7.88
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 7.87
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 7.87
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 7.84
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 7.78
Accurate annotation of human protein-coding small open reading frames 7.75
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 7.73
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 7.69
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 7.68
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 7.64
RNA-seq in transgenic cells 7.6
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 7.6
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 7.6
Total RNA sequencing of WT intestinal orgaonids. 7.59
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 7.57
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 7.54
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 7.52
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 7.41
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 7.41
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 7.39
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 7.39
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 7.38
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 7.38
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 7.38
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 7.36
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 7.32
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 7.32
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 7.23
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 7.23
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 7.22
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 7.17
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 7.09
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 7.09
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 7.09
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 7.08
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 7.08
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 7.01
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 6.97
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 6.97
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 6.96
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 6.96
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 6.85
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 6.85
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 6.84
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 6.82
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 6.82
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 6.82
Functional role of CPPED1 in trophoblasts. 6.76
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 6.74
Examining serotonergic neuron differentiation from human iPSCs 6.73
RNA-seq analyses of human prostate cancer cells 6.7
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 6.69
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 6.67
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 6.66
RNA sequencing of BT142 and TS603 cell lines 6.66
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 6.65
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 6.61
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 6.59
RNAseq of HEK293 cells after Chtop knockdown 6.56
Co-transcriptional loading of RNA export factors shapes the human transcriptome 6.56
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 6.55
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 6.55
6.51
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 6.48
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 6.45
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 6.4
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 6.4
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 6.4
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 6.32
TGF-β promotes genomic instability after loss of RUNX3 6.32
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 6.31
Studying the selectivity of a small molecule Synucleozid on transcriptome 6.29
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 6.28
RNA-seq of naive and primed ES cells 6.27
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 6.27
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 6.21
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 6.2
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 6.18
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 6.18
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 6.17
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 6.1
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 6.1
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 6.09
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 6.09
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 6.08
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 6.03
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 6.01
Epigenomic landscape during organ formation in human early embryos 5.99
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 5.97
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 5.96
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 5.91
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 5.91
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 5.9
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 5.9
PNET animal model: new insights (II) 5.86
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 5.81
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 5.81
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 5.77
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 5.77
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 5.77
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 5.7
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 5.68
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 5.64
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 5.63
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 5.61
JAK dependent survival of ALK- ALCL 5.61
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 5.59
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 5.58
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 5.49
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 5.47
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 5.44
Dtx3L and Androgen Signaling in Prostate Cancer 5.4
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 5.37
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 5.37
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 5.34
Dynamic reorganization of nuclear architecture during human cardiogenesis 5.33
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 5.33
Epigenome regulation during epidermal lineage commitment 5.31
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 5.3
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 5.3
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 5.29
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 5.26
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 5.26
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 5.26
Identification of long noncoding RNAs regulated by p53 5.25
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 5.24
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 5.24
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 5.23
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.21
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.21
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 5.21
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 5.18
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 5.18
Functional role of SLIT2 and ROBO1 in trophoblasts 5.16
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 5.14
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 5.13
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 5.12
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 5.09
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 5.09
Chromatin-informed inference of transcriptional programs in gynecologic cancers 5.05
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 5.05
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 5.02
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 5.02
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 4.99
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 4.99
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 4.99
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 4.98
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 4.98
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 4.95
Gene expression profile in breast cancer cell lines using RNA sequencing 4.94
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 4.93
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 4.9
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 4.89
The landscape of alternative splicing in aggressive prostate cancers 4.88
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 4.87
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 4.87
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 4.85
In vitro modeling of human germ cell development using pluripotent stem cells 4.81
O-glcnAc reprograms cellular energetics 4.76
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 4.74
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 4.7
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 4.68
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 4.67
AMPK signaling for naïve pluripotency [Hs] 4.67
AMPK signaling for naïve pluripotency 4.67
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 4.65
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 4.63
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 4.58
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 4.57
Endometrial transcriptome and PGR cistrome in cycling fertile women 4.52
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 4.52
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.52
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.52
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 4.45
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 4.43
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 4.39
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 4.39
Discovering human diabetes-risk gene function with genetics and physiological assays 4.39
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 4.38
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 4.34
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 4.3
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 4.3
NHLRC1 re-expression in cancer cells 4.26
Molecular Criteria for Defining the Naive Human Pluripotent State 4.25
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 4.24
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 4.22
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 4.17
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 4.17
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 4.13
Transcriptome analysis of H9 hESC derived cerebral organoids 4.1
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 4.09
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 4.04
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 4.01
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 4.0
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 3.97
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 3.96
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.91
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 3.84
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 3.84
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 3.84
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 3.82
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 3.73
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 3.65
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 3.65
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 3.63
The DPYSL2 gene connects mTOR and schizophrenia 3.62
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 3.57
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 3.54
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 3.51
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 3.45
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 3.43
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 3.38
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 3.32
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 3.32
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 3.31
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 3.29
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 3.28
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 3.26
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 3.24
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.22
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 3.2
Transcriptome of EBV-infected gastric cancer cell lines 3.18
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 3.08
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 3.08
Clinker: visualizing fusion genes detected in RNA-seq data 3.07
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 3.01
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 3.01
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 2.98
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 2.9
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 2.9
Generating Patterned Kidney Organoids for Studying Development and Diseases 2.89
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 2.85
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 2.85
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 2.82
Retinoic acid suppresses MYB in adenoid cystic carcinoma 2.79
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 2.79
FGF2 regulation of gene expression in stable inducible Neurons 2.78
Searching for target genes of miR-508/509/506/514 in HCT116 cells 2.77
Disruption of GRIN2B impairs differentiation in human neurons 2.69
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 2.59
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 2.57
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.56
RNA-seq analysis of the human fetal kidney. 2.54
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.52
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 2.51
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.46
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 2.4
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.4
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.4
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 2.38
PRDM1 inhibits proliferation of human colon cancer organoids 2.29
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 2.15
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 2.11
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 2.11
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 2.06
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 2.02
Human ovarian granulosa cell transcriptome 2.0
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.92
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 1.89
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.85
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 1.83
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 1.79
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 1.77
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 1.65
Gene profiling of human adult and pediatric liver cancer cells 1.63
RNA-Seq in PWS iPSC-derived neurons 1.6
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 1.53
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 1.52
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 1.52
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 1.49
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 1.49
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.44
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.4
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.4
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.32
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 1.24
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 1.24
Derivation and differentiation of haploid human embryonic stem cells 1.24
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 1.2
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 1.13
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 1.01
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 1.01
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.97
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.97
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.96
RNAseq analysis of ruxolitinib treated breast cancers 0.96
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.96
Hepatic transcriptome of pediatric hepatoblastoma. 0.93
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.9
Function and hormonal regulation of GATA3 in human first trimester placentation 0.86
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.84
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.79
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.78
Zika virus directly infects human peripheral neurons and induces cell death 0.77
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.74
Dissecting neural differentiation regulatory networks through epigenetic footprinting 0.73
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.72
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.67
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.67
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.65
The cohesin release factor WAPL restricts chromatin loop extension. 0.57
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 0.57
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.57
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.54
Gene expression analysis of breast cancer cell-lines 0.54
The effect of insulin on mRNA transcription of human pluripotent stem cells 0.54
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.52
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 0.51
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.5
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.5
RNA-seq of cancer cell lines treated with T-025 0.49
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.49
CHCHD2 gene KO effect in iPSC drived motor neurons 0.46
mRNA sequencing of oropharyngeal cancer cell lines 0.42
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 0.4
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 0.4
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.4
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 0.39
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.27
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.26
Identification of a LIF-responsive replication-competent human β cell 0.21
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.21
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.19
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.16
HEK293 TFAM Knockout Expression Study 0.1
Effect of nuclear IL-33 on gene expression 0.06
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 0.03
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation